Back

Discussant review - CIRRUS­HCM

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Hottest trials and trial updates (2) Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Iacopo Olivotto

University of Florence, Florence (Italy)

20 More presentations in this session

Presentation thumbnail
DIGIT­HF: Baseline characteristics compared to recent trials in heart failure with reduced ejection fraction
Professor U. Bavendiek (Hannover, DE)
Slides Video
Presentation thumbnail
Discussant review - DIGIT­HF
Professor D. van Veldhuisen (Groningen, NL)
Slides Video
Presentation thumbnail
Panel discussion - DIGIT­HF
Video
Presentation thumbnail
CIRRUS­HCM: A multiple-dose phase 2 study of safety, tolerability, and effects on hemodynamics and functional capacity of the novel cardiac sarcomere modulator EDG-7500 in hypertrophic cardiomyopathy
Doctor A. Owens (Philadelphia, US)
Slides Video
Presentation thumbnail
Panel discussion - CIRRUS­HCM
Video

Access the full session

Session thumbnail
Hottest trials and trial updates (2)
Video

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
CIRRUS­HCM: A multiple-dose phase 2 study of safety, tolerability, and effects on hemodynamics and functional capacity of the novel cardiac sarcomere modulator EDG-7500 in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Summary, panel discussion and Q&A
thumbnail
Congress Presentation
Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources